Ernexa Therapeutics Inc. Property, Plant and Equipment, Other, Gross
Ernexa Therapeutics Inc. (ERNA) had Property, Plant and Equipment, Other, Gross of $1.09 million as of 2019-12-31, per its 10-K filed 2020-03-19.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentOther · last filed 2020-03-19
- 2019-12-31: Property, Plant and Equipment, Other, Gross $1.09M.
- 2019-09-30: Property, Plant and Equipment, Other, Gross $1.60M.
- 2019-06-30: Property, Plant and Equipment, Other, Gross $1.69M.
- 2019-03-31: Property, Plant and Equipment, Other, Gross $2.18M.
| Period end | Property, Plant and Equipment, Other, Gross |
|---|---|
| 2019-12-31 | $1.09M 10-K · filed 2020-03-19 |
| 2019-09-30 | $1.60M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $1.69M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.18M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $2.54M 10-K · filed 2020-03-19 |
| 2018-09-30 | $3.60M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $3.80M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $3.99M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $4.87M 10-K · filed 2019-03-22 |
| 2017-09-30 | $4.65M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $2.46M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $2.57M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $3.00M 10-K · filed 2018-03-09 |
| 2016-09-30 | $2.91M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.98M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $3.76M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $3.99M 10-K · filed 2017-03-09 |
| 2015-09-30 | $3.42M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $3.14M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $4.20M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $4.75M 10-K · filed 2016-03-15 |
| 2013-12-31 | $1.07M 10-K · filed 2015-03-27 |
| 2012-12-31 | $24.00K 10-K · filed 2013-03-29 |
| 2011-12-31 | $24.00K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |